MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/21.03.25 Stock

Warrant

DE000MB5S4Y4

Market Closed - Bid/Ask 14:09:33 2024-06-26 EDT Pre-market 02:36:30
0.035 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/21.03.25 0.04 +14.29%
Current month+2.94%
1 month-2.78%
Date Price Change
24-06-26 0.035 0.00%
24-06-25 0.035 -2.78%
24-06-24 0.036 0.00%
24-06-21 0.036 -10.00%
24-06-20 0.04 +25.00%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 02:09 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB5S4Y
ISINDE000MB5S4Y4
Date issued 2023-04-21
Strike 160 $
Maturity 2025-03-21 (268 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.021
Spread 0.024
Spread %46.15%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus